Pulsed Electrical Stimulation for Mesenchymal Stem Cell EV Yield
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing therapeutic extracellular vesicles (EVs) from Mesenchymal Stem Cells face challenges such as low yield, lack of control over EV content, and inefficiencies in pre-conditioning techniques like genetic modification, chemical stimulation, mechanical stimulation, and irradiation, which hinder their application in regenerative therapy.
Innovation Solution
A method involving direct pulsed electrical stimulation of Mesenchymal Stem Cells using metallic electrodes at specific conditions, which increases EV production 4 to 5-fold and modifies the EV cargo to enhance regenerative properties, particularly for neural tissue regeneration, without causing electroporation or compromising cell viability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional EV production methods are used, then the process is simple, but the EV yield is low
Solution Approach 1:
The patent applies preliminary action by pre-conditioning Mesenchymal Stem Cells with direct pulsed electrical stimulation before EV harvest. This pre-treatment modifies the cellular state to enhance subsequent EV production, achieving 4-5 fold increase in yield without complicating the overall production workflow
Solution Approach 2:
The patent utilizes parameter changes by applying specific electrical stimulation parameters (voltage, frequency, pulse duration) to MSCs. These controlled physical parameter changes trigger cellular responses that significantly boost EV production while maintaining process simplicity
2Productivity
If genetic modification is used to increase EV yield, then the EV production increases, but the manufacturing complexity and regulatory requirements increase
Solution Approach 1:
The patent replaces genetic modification approaches with a physical stimulation method (direct pulsed electrical stimulation). This substitution eliminates the need for complex genetic engineering workflows, transfection reagents, and associated regulatory burdens while achieving superior EV yield enhancement
Solution Approach 2:
The electrical stimulation method activates the cell's own EV production machinery without external genetic intervention. The MSCs themselves, when subjected to controlled electrical fields, autonomously increase their EV secretion capacity, eliminating the need for exogenous genetic elements
3Productivity
If irradiation is used for pre-conditioning, then the EV production increases, but the cell viability decreases due to cytotoxicity
Solution Approach 1:
The patent converts the potentially harmful effect of electrical fields into a beneficial outcome by using controlled direct pulsed electrical stimulation within safe voltage ranges. This approach harnesses the cell's natural electrophysiological responses to enhance EV production without causing the cytotoxic damage associated with irradiation methods
Solution Approach 2:
The patent applies electrical stimulation at optimized partial doses that are sufficient to trigger EV production enhancement but remain below cytotoxic thresholds. By carefully controlling the extent of electrical exposure (voltage, pulse duration, frequency), the method achieves beneficial effects without harmful consequences
4Quantity of substance
If chemical pre-conditioning is used, then the EV cargo content increases, but the manufacturing complexity and regulatory burden increase
Solution Approach 1:
The patent replaces chemical pre-conditioning methods with direct pulsed electrical stimulation. This substitution eliminates the need for complex chemical reagent protocols, incubation steps, and associated quality control requirements while effectively enhancing EV cargo content through physical cellular stimulation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method significantly boosts EV production and modifies their cargo to include proteins beneficial for neural regeneration and survival, demonstrating augmented regenerative effects when applied to human brain organoids, and can be used in tissue repair, wound healing, bone regeneration, and immune modulation.
Implementation Method 1
direct pulsed electrical stimulation... the plurality of metallic electrodes (1) located inside the cell culture wells of the electrical stimulation device and in direct contact with the cell culture medium and/or the Mesenchymal Stem Cells
Implementation Method 2
the electrical stimulation device producing an electric field of between 10 mV/mm and 100 mV/mm
Data Source
Figure 1A~1B
Figure 1C~1D
Figure 2A
AI summary
The present invention relates to a method for the production of therapeutic extracellular vesicles (EVs) from Mesenchymal Stem Cells by applying a direct pulsed electrical stimulation to said Mesenchymal Stem Cells. Furthermore, the present invention also discloses the EVs, the composition or the kit comprising them, and their use in regenerative therapy and the delivery of drugs.